Inhibition of DNA synthesis by cytosine arabinoside: Relation to response of acute non-lymphocytic leukemia to remission induction therapy and to stage of the disease

Proposals for the Classification of the Acute Leukaemias F<scp>rench</scp>‐A<scp>merican</scp>‐B<scp>ritish</scp> (FAB) C<scp>o‐operative</scp> G<scp>roup</scp>

John M. Bennett, Daniel Catovsky, Marie‐Theregse Daniel et al. · British Journal of Haematology · 1976 · 5.6K citations

Medicine, Hematology, Pathology +17

Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B

KR Rai, JF Holland, O Glidewell et al. · Blood · 1981 · 447 citations · Full text

Medicine, Hematology, Oncology +13

Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B

KR Rai, JF Holland, O Glidewell et al. · Blood · 1981 · 418 citations

Medicine, Hematology, Oncology +13

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia

Seth A. Rudnick, E Cadman, Robert L. Capizzi et al. · Cancer · 1979 · 287 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.

Pierre Major, E.Michael Egan, G. Peter Beardsley et al. · Proceedings of the National Academy of Sciences · 1981 · 201 citations · Full text

Medicine, Hematology, Molecular Biology +12